<code id='19D7CBFDC8'></code><style id='19D7CBFDC8'></style>
    • <acronym id='19D7CBFDC8'></acronym>
      <center id='19D7CBFDC8'><center id='19D7CBFDC8'><tfoot id='19D7CBFDC8'></tfoot></center><abbr id='19D7CBFDC8'><dir id='19D7CBFDC8'><tfoot id='19D7CBFDC8'></tfoot><noframes id='19D7CBFDC8'>

    • <optgroup id='19D7CBFDC8'><strike id='19D7CBFDC8'><sup id='19D7CBFDC8'></sup></strike><code id='19D7CBFDC8'></code></optgroup>
        1. <b id='19D7CBFDC8'><label id='19D7CBFDC8'><select id='19D7CBFDC8'><dt id='19D7CBFDC8'><span id='19D7CBFDC8'></span></dt></select></label></b><u id='19D7CBFDC8'></u>
          <i id='19D7CBFDC8'><strike id='19D7CBFDC8'><tt id='19D7CBFDC8'><pre id='19D7CBFDC8'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:83777
          Ron Wyden, left, and Mike Crapo, right. -- health policy coverage from STAT
          Sens. Ron Wyden and Mike Crapo passed a new slate of pharmacy benefit manager reforms through the Finance Committee. Kevin Dietsch/Getty Images

          WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications.

          The package passed the committee 26-0 with no amendments added. Sen. Ron Johnson (R-Wis.) didn’t vote.

          advertisement

          The package, crafted by Senate Finance Chair Ron Wyden (D-Ore.) and Mike Crapo (R-Idaho) also includes policy on a broad range of health care priorities, including substance abuse and mental health care and extensions to provider pay. The pharmacy benefit manager regulations build on a separate package of PBM regulations that the panel passed in July.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Readout LOUD podcast: ASCO preview, a Duchenne trial failure
          Readout LOUD podcast: ASCO preview, a Duchenne trial failure

          WhichpresentationsareworthcatchingatASCOthisweekend?Whatisexon-skipping?Andhowdoyoupronouncebronchie

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Readout LOUD podcast: Venture capital turmoil, obesity drug competition

          Whyareaddictiontreatmentssohardtoget?Cansmallcompaniescompeteinobesity?Andsincewhenis“SeriesE”athing